Mental Health Clinics in Duncansville, PA Accepting Medicare
3 Mental Health Clinics found. Showing 1 - 3
 Emmaus Counseling Services Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 117 Olde Farm Office Rd Ste 204, Duncansville, PA 16635 Phone: 814-808-9538 |
Catherine Selth Spayd Phd Pc Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 841 Third Avenue, Duncansville, PA 16635 Phone: 814-693-0617 Fax: 814-693-0617 |
Becky L. Ropp-llc Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 1414b 3rd Ave, Duncansville, PA 16635 Phone: 814-693-8900 |
News Archive
Barr announces approval of generic version of Yasmin (drospirenone and ethinyl estradiol)
Barr Pharmaceuticals, Inc. has announced that its subsidiary, Barr Laboratories, Inc., has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) to manufacture and market a generic version of Yasmin (drospirenone and ethinyl estradiol), an oral contraceptive product manufactured and marketed by Bayer Schering Pharma, AG.
Emergency physicians encourage safe fireworks practices
Fireworks sales will be blazing across the country from now through the Fourth of July. As retailers begin their promotions, the Pennsylvania Academy of Ophthalmology, the Pennsylvania College of Emergency Physicians, and the Pennsylvania Medical Society join the American Academy of Ophthalmology in shining light on the explosive fact: fireworks injuries cause approximately 10,000 visits to the emergency room each year, according to the data from the U.S. Consumer Product Safety Commission.
Next generation predictive 3D cell toxicity assays to be developed by Medicyte GmbH and Reinnervate Ltd
Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.
Study offers hope for treatment of Krabbe disease
In one out of 100,000 infants, a mutation in the GALC gene causes an incurable, always fatal disorder known as infantile Krabbe disease, or globoid cell leukodystrophy. Most children with the condition die before they turn 2.
› Verified 6 days ago